Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Rigen Biotech
company
About
Rigen Biotech focuses on the molecular diagnosis of thyroid tumors.
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- ¥100M
- Industries
- Biotechnology,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2017
- Operating Status
- Active
Rijing Biosciences has launched thyroid biopsy needles, multi-gene qPCR detection and NGS detection, Thyroscan® thyroid nodule benign and malignant classifier, and targeted surgery for thyroid cancer from preoperative sampling, diagnosis, to postoperative monitoring. Full-process series products such as post-recurrence monitoring provide a variety of solutions for the entire thyroid cancer diagnosis and treatment cycle.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥100M
Rigen Biotech has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Apr 14, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 14, 2022 | Series Unknown | ¥100M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Rigen Biotech is funded by 1 investors.
Yinshengtai Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
